Bayer, Syngenta Secure Major US Victories on Glyphosate, Dicamba, and Atrazine

Agrichemical giant Bayer AG has secured a landmark U.S. Supreme Court victory limiting cancer-related lawsuits over its Roundup weedkiller, headlining a series of recent legal and regulatory wins for the pesticide industry. The decision is a major development for Bayer, which has been mired in costly litigation since its 2018 acquisition of Monsanto.

Supreme Court Shields Bayer in Roundup Litigation

The most significant victory for the industry came on June 25, when the U.S. Supreme Court ruled in a 7-2 decision that plaintiffs cannot sue Bayer for failing to include cancer-risk warnings on its Roundup product under state laws. Bayer has long argued that federal law, which does not require such a warning, preempts state-level requirements.

The ruling sent Bayer's shares soaring to their largest gains in 23 years, according to Reuters. The company, which faces tens of thousands of similar lawsuits, is now seeking to dismantle a consolidated federal litigation that includes nearly 4,000 cases, a move that would lift a major financial overhang. Bayer called the decision "good for science, farmers, and industries that depend on regulatory clarity for innovation."

Favorable Rulings on Dicamba and Atrazine

The industry has also seen positive outcomes for other highly debated chemicals, signaling a potentially more favorable regulatory environment.

Ad

• Dicamba: In February 2026, the U.S. Environmental Protection Agency (EPA) re-approved the weedkiller, manufactured by Bayer and Syngenta, for the next two growing seasons. The approval came with new restrictions after a U.S. District Court had vacated previous registrations in 2024, preventing its use in 2025.
• Atrazine: In April, the U.S. Fish and Wildlife Service issued a biological opinion concluding that the Syngenta-produced herbicide does not pose an extinction risk to the threatened and endangered species it studied. This marked a shift from a 2021 EPA evaluation that found the chemical was likely to adversely affect over 1,000 protected species.

A Shifting Regulatory Landscape

These developments have been interpreted by environmental advocates as a significant policy shift. Ken Cook, CEO of the non-profit Environmental Working Group, told Reuters that the Trump administration seems to have decided that "our constituency is these big farmers and pesticide companies," calling it a "big shift" from the more cautious approach of the previous administration.

Conversely, the EPA stated its decisions, which include new restrictions, mean that "growers get modern, more precise chemistries that do more with less." Despite the industry's wins, environmental groups like the Center for Biological Diversity continue to challenge the decisions, arguing the new measures on products like dicamba will be "ineffective and difficult to enforce."